Blinded Reference Set for Multicancer Early Detection Blood Tests

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05334069

Title field or adapter rule

{'original_value': 'Blinded Reference Set for Multicancer Early Detection Blood Tests', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:21.803860+00:00

Published At

2026-10-28T00:00:00+00:00

Record Updated At

2026-10-28

Source Retrieved At

2026-10-31T22:18:28.651351+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Ann Arbor Stage I Lymphoma", "Ann Arbor Stage II Lymphoma", "Ann Arbor Stage III Lymphoma", "Ann Arbor Stage IV Lymphoma", "Chronic Lymphocytic Leukemia", "Chronic Myeloid Leukemia", "Gastroesophageal Junction Adenocarcinoma", "Head and Neck Carcinoma", "Hematopoietic and Lymphoid Cell Neoplasm", "Invasive Breast Carcinoma", "Kidney Carcinoma", "Malignant Hepatobiliary Neoplasm", "Malignant Solid Neoplasm", "Melanoma", "Muscle-Invasive Bladder Carcinoma", "Stage I Bladder Cancer AJCC v6 and v7", "Stage I Breast Cancer AJCC v7", "Stage I Colorectal Cancer AJCC v6 and v7", "Stage I Esophageal Cancer AJCC V7", "Stage I Gastric Cancer AJCC V7", "Stage I Lung Cancer AJCC v7", "Stage I Ovarian Cancer AJCC v6 and v7", "Stage I Pancreatic Cancer AJCC v6 and v7", "Stage I Prostate Cancer AJCC v7", "Stage I Uterine Corpus Cancer AJCC v7", "Stage II Bladder Cancer AJCC v6 and v7", "Stage II Breast Cancer AJCC v6 and v7", "Stage II Colorectal Cancer AJCC v7", "Stage II Esophageal Cancer AJCC v7", "Stage II Gastric Cancer AJCC v7", "Stage II Lung Cancer AJCC v7", "Stage II Ovarian Cancer AJCC v6 and v7", "Stage II Pancreatic Cancer AJCC v6 and v7", "Stage II Prostate Cancer AJCC v7", "Stage II Uterine Corpus Cancer AJCC v7", "Stage III Bladder Cancer AJCC v6 and v7", "Stage III Breast Cancer AJCC v7", "Stage III Colorectal Cancer AJCC v7", "Stage III Esophageal Cancer AJCC v7", "Stage III Gastric Cancer AJCC v7", "Stage III Lung Cancer AJCC v7", "Stage III Ovarian Cancer AJCC v6 and v7", "Stage III Pancreatic Cancer AJCC v6 and v7", "Stage III Prostate Cancer AJCC v7", "Stage III Uterine Corpus Cancer AJCC v7", "Stage IV Bladder Cancer AJCC v7", "Stage IV Breast Cancer AJCC v6 and v7", "Stage IV Colorectal Cancer AJCC v7", "Stage IV Esophageal Cancer AJCC v7", "Stage IV Gastric Cancer AJCC v7", "Stage IV Lung Cancer AJCC v7", "Stage IV Ovarian Cancer AJCC v6 and v7", "Stage IV Pancreatic Cancer AJCC v6 and v7", "Stage IV Prostate Cancer AJCC v7", "Stage IV Uterine Corpus Cancer AJCC v7", "RISS Stage I Multiple Myeloma", "RISS Stage II Multiple Myeloma", "RISS Stage III Multiple Myeloma"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-28", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT05334069"

protocolSection.identificationModule.officialTitle

"Blinded Reference Set for Multicancer Early Detection Blood Tests"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

null

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
• Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Ann Arbor Stage I Lymphoma (protocolSection.conditionsModule.conditions)
• Ann Arbor Stage II Lymphoma (protocolSection.conditionsModule.conditions)
• Ann Arbor Stage III Lymphoma (protocolSection.conditionsModule.conditions)
• Ann Arbor Stage IV Lymphoma (protocolSection.conditionsModule.conditions)
• Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
• Chronic Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Gastroesophageal Junction Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Head and Neck Carcinoma (protocolSection.conditionsModule.conditions)
• Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)
• Invasive Breast Carcinoma (protocolSection.conditionsModule.conditions)
• Kidney Carcinoma (protocolSection.conditionsModule.conditions)
• Malignant Hepatobiliary Neoplasm (protocolSection.conditionsModule.conditions)
• Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)
• Melanoma (protocolSection.conditionsModule.conditions)
• Muscle-Invasive Bladder Carcinoma (protocolSection.conditionsModule.conditions)
• Stage I Bladder Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage I Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage I Colorectal Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage I Esophageal Cancer AJCC V7 (protocolSection.conditionsModule.conditions)
• Stage I Gastric Cancer AJCC V7 (protocolSection.conditionsModule.conditions)
• Stage I Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage I Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage I Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage I Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage I Uterine Corpus Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Bladder Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage II Breast Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage II Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Esophageal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage II Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage II Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage II Uterine Corpus Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Bladder Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage III Breast Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Esophageal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage III Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage III Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage III Uterine Corpus Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Bladder Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Breast Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Esophageal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Gastric Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Lung Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Ovarian Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
• Stage IV Prostate Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• Stage IV Uterine Corpus Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
• RISS Stage I Multiple Myeloma (protocolSection.conditionsModule.conditions)
• RISS Stage II Multiple Myeloma (protocolSection.conditionsModule.conditions)
• RISS Stage III Multiple Myeloma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Screening (questionnaire, biospecimen collection)'], 'description': 'Complete questionnaire', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Screening (questionnaire, biospecimen collection)'], 'description': 'Undergo collection of tissue and blood samples', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.